In addition, a PDA‐based NP system was developed to enhance PTT in cancer cells by inducing autophagy.[329] The PDA NPs were modified with PEG for stability and further functionalized with Beclin‐1‐derived peptides to stimulate autophagy and RGD peptides for enhanced tumor targeting. This evidence concerns the gene BECN1 and neoplasm.